Cita APA (7a ed.)
Liu, J., Han, L., Wu, L., Chen, J., Sun, H., Wen, G., . . . Arkania, E. (2026). First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial. JAMA Oncology, 12(8), 810-819.
Cita Chicago Style (17a ed.)
Liu, Jingjing, et al. "First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial." JAMA Oncology 12, no. 8 (2026): 810-819.
Cita MLA (9a ed.)
Liu, Jingjing, et al. "First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial." JAMA Oncology, vol. 12, no. 8, 2026, pp. 810-819.
Precaución: Estas citas no son 100% exactas.